Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology - Wikidata - wikimedia - TriplyDB

Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology

Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology

http://www.wikidata.org/entity/Q37116964

about

Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements Comparative transcriptome and proteome analysis to reveal the biosynthesis of gold nanoparticles in Arabidopsis.Genome wide transcriptome analysis reveals ABA mediated response in Arabidopsis during gold (AuCl(-) 4) treatment Mitochondria-targeting particles.Nanocrystalline cerium dioxide efficacy for gastrointestinal motility: potential for prokinetic treatment and prevention in elderly.Role of gold nanoparticles as drug delivery vehicles for chondroitin sulfate in the treatment of osteoarthritis.Probiotics and immunity: provisional role for personalized diets and disease prevention.Efficacy of gold nanoparticles against isoproterenol induced acute myocardial infarction in adult male albino rats.Predictive diagnosis of endometrial hyperplasia and personalized therapeutic strategy in women of fertile age.Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesions The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention.PEG-coated gold nanoparticles attenuate β-adrenergic receptor-mediated cardiac hypertrophy.Gold nanoparticles: challenge of PPPM for heart failure treatment and drug delivery.Natural Antioxidants as Potential Therapy, and a Promising Role for Melatonin Against Pulmonary Hypertension.Characterization of Cardiac Dynamics in an Acute Myocardial Infarction Model by Four-Dimensional Optoacoustic and Magnetic Resonance Imaging.Conjugating Existing Clinical Drugs With Gold Nanoparticles for Better Treatment of Heart Diseases.Cyanobacteria as Nanogold Factories: Chemical and Anti-Myocardial Infarction Properties of Gold Nanoparticles Synthesized by Lyngbya majuscula.

P2860

Q30360668-EFD8CCCE-4129-447E-82DB-95608AB5BD3A Q30361646-F965B549-DB20-4B53-96AE-35413C324668 Q30373738-8D450DDD-107E-498C-A4A0-0FC8055DE8DA Q30385765-CFF5926E-A0EF-4AFA-8783-DE8A9E254E20 Q34582669-2A2D6F51-401A-4569-B0FA-3682A5F34501 Q34960940-FFF9C535-5388-4FB9-B962-ED3376EE1B82 Q35219044-582611F2-7011-486B-BE75-D1121A2A8AD2 Q35700763-FFE51D3F-2976-45C4-8A45-0B284D80D3F7 Q35896143-65AF3F70-A2EB-470F-A9F7-227AE6605AAB Q36301960-ECE4F43B-AC7A-4738-8CF1-86972120B173 Q37399772-905A3461-80C9-400B-A9F8-4B56B1275312 Q37511930-D67ADC4A-94F4-4E36-904A-B5A02C77243C Q37580976-A39B63D3-20DE-4337-A340-AB5532EDE43A Q40970624-3D17ECF9-CC76-4480-82BE-52A6E4FF133A Q46042245-9FB65B5D-03BF-42D0-A3D4-51D29D8E8E09 Q46183692-F9BDA0DF-F1FD-4B34-A2F6-05FDD53D9E95 Q47233182-0A7DF98C-1D2F-489A-8163-4399104C49D7 Q55074524-AA8EB9A4-7CC9-41F2-BEE5-3A596BFF1E2B Q55508127-07847B11-E32B-4F53-990E-6FFE92D15C5F

P2860

Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology

http://www.wikidata.org/entity/Q37116964

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Development and testing of gol ...... c potential for PPP cardiology

@en

Development and testing of gol ...... potential for PPP cardiology.

@nl

type

label

Development and testing of gol ...... c potential for PPP cardiology

@en

Development and testing of gol ...... potential for PPP cardiology.

@nl

prefLabel

Development and testing of gol ...... c potential for PPP cardiology

@en

Development and testing of gol ...... potential for PPP cardiology.

@nl

P1433

Q37116964-2E85613F-6DB9-4F8E-86AE-2E82C4FA061E

P1476

Q37116964-FB78F658-6CFB-4724-8E1E-17BB70A63D0B

P2093

Q37116964-12178756-FC5E-4270-BBE8-8F7B04E2C8D0

Q37116964-290406FC-6162-4745-953B-95AF94C69ED1

Q37116964-5501B439-4455-450C-A88D-30CD40148B19

Q37116964-DC61615E-BBFB-4EB2-B3D4-BB788793C39B

P2860

Q37116964-02E573EF-1342-4B4E-B9E8-F92ACE9D7246

Q37116964-08C5F85A-DF55-4F6A-B63C-771CF7CA7D07

Q37116964-105E5575-8F0F-4E7D-BFB5-C684A030D64B

Q37116964-14662EE4-A5D3-4430-BD2D-E6771DCC68B2

Q37116964-16E3C342-5636-499E-BCB9-13FE8F7FE4D1

Q37116964-1B6CF624-5FDD-42D0-B775-950B7CEBA3E0

Q37116964-44227E2F-0940-48A1-8F52-12EF6D214DD1

Q37116964-44C81AD8-E730-4784-B2C1-0EFEC830C9B0

Q37116964-4A8A7E07-2CCA-4DC8-81BC-4CF728C36B0F

Q37116964-5A1731E7-1729-4CEC-9ABD-F5A8C8EC0C56

P2888

Q37116964-A07CE962-CAFE-408B-9964-F67115F10D8C

P304

Q37116964-B27D0CDE-E467-419B-AB37-A3FC22AF1982

P31

Q37116964-5B862928-FB1A-4297-B026-7EA5FEF8ACD5

P356

Q37116964-DB1F6591-7842-4554-92D7-90A2C845B2C6

P433

Q37116964-7B27982F-B41D-4ED9-A794-0B9359FAFFFD

P478

Q37116964-3B141FA0-0676-4C89-BAEB-2059D9F03CBD

P50

Q37116964-5A9B3AA3-8E44-4932-98D6-5F5767C3E332

Q37116964-8F53F7EF-BB89-49FA-B808-108C3697B270

P577

Q37116964-A13F16E4-35DD-45AA-AC2D-3A7CAA8E6ADE

P5875

Q37116964-E3F596F7-588F-4B36-B240-5F04BA51545B

P6179

Q37116964-559BE61B-4D9B-4690-AE2F-AA1798572399

P698

Q37116964-396D6F6A-12D2-41A6-AD9E-6EEB46DE7CD4

P921

Q37116964-62E827DA-6210-4A68-B78A-50988AC53234

Q37116964-AA249EA3-AB0D-4F87-92B6-92DA13526F03

Q37116964-BDF9874B-7A4F-4B00-8977-A70AEE63E400

P932

Q37116964-3A054F8B-908D-4897-81C2-773AF2DB7410

P356

P1433

The EPMA journal

P1476

Development and testing of gol ...... c potential for PPP cardiology

@en

P2093

Ilya M Yemets

http://www.w3.org/2001/XMLSchema#string

Liudmyla M Lazarenko

http://www.w3.org/2001/XMLSchema#string

Natalia O Tymoshok

http://www.w3.org/2001/XMLSchema#string

Zoia R Ulberg

http://www.w3.org/2001/XMLSchema#string

P2860

Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables

A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis

Nanoparticles, human health hazard and regulation

Oxidative stress, antioxidants and stress tolerance

The failing heart--an engine out of fuel

Gold nanoparticles - the theranostic challenge for PPPM: nanocardiology application.

Evidence-based pain management: is the concept of integrative medicine applicable?

Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers.

Noninvasive monitoring of cardiac function in a chronic ischemic heart failure model in the rat: assessment with tissue Doppler and non-Doppler 2D strain echocardiography.

Optical properties and ultrafast dynamics of metallic nanocrystals.

P2888

P304

20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1878-5085-4-20

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Rostyslav V. Bubnov

P577

2013-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

253331796

http://www.w3.org/2001/XMLSchema#string

P6179

1026942152

http://www.w3.org/2001/XMLSchema#string

P698

23889805

http://www.w3.org/2001/XMLSchema#string

P921

P932

3751918

http://www.w3.org/2001/XMLSchema#string